Spyre Therapeutics
SYRE
SYRE
129 hedge funds and large institutions have $1B invested in Spyre Therapeutics in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 52 increasing their positions, 35 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
129
Holders Change
-2
Holders Change %
-1.53%
% of All Funds
1.75%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
20
Increased
52
Reduced
35
Closed
21
Calls
$827K
Puts
$1.01M
Net Calls
-$182K
Net Calls Change
-$264K
Top Buyers
Top Sellers
1 |
Citadel Advisors
Miami,
Florida
|
-$15.3M |
2 |
LGM
Logos Global Management
San Francisco,
California
|
-$11.6M |
3 |
BCM
Boxer Capital Management
San Diego,
California
|
-$10.9M |
4 |
Goldman Sachs
New York
|
-$8.88M |
5 |
Janus Henderson Group
London,
United Kingdom
|
-$7.45M |